{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:38:54Z","timestamp":1771486734523,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the effect of administering postpartum heparin-based pharmacologic thromboprophylaxis on the incidence of postpartum venous thromboembolism (VTE) and complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a multicenter retrospective cohort study of all individuals delivering at more than 20 weeks of gestation at four U.S. hospitals from 2016 to 2019. Individuals with a personal history of VTE or thrombophilia, with an antepartum diagnosis of VTE, or receiving therapeutic anticoagulation were excluded. The exposure was postpartum heparin-based pharmacologic prophylaxis (including unfractionated and low-molecular-weight formulations). The primary outcome was VTE identified within 12 weeks of delivery. Secondary outcomes included hospital readmission and wound complications among individuals undergoing cesarean delivery. Baseline characteristics were compared between those receiving and those not receiving pharmacologic thromboprophylaxis. Augmented inverse probability of treatment weighting was used to estimate risk difference in outcomes among those who received prophylaxis. The effects are reported as a risk difference with 95% CIs. Positive and negative effects indicate benefit and harm, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 64,886 deliveries included, the rate of heparin-based postpartum pharmacologic thromboprophylaxis was 13.8% (95% CI, 13.5\u201314.1%), and the rate of VTE was 0.11% (95% CI, 0.09\u20130.14%). Individuals receiving thromboprophylaxis were more likely to be older, to deliver by cesarean, and to have a comorbid health condition. In propensity score analysis, pharmacologic prophylaxis compared with no pharmacologic prophylaxis resulted in no difference in VTE (risk difference 0.0%, 95% CI, 0\u20130.16%) but an increased risk for hospital readmission (risk difference \u22121.36%, 95% CI, \u22122.51 to \u22120.14%) and wound complications (risk difference \u22121.45%, 95% CI, \u22122.35 to \u22120.65%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Use of postpartum pharmacologic thromboprophylaxis did not reduce postpartum VTE in this U.S. cohort. Findings may reflect persistent confounding despite covariate adjustment or suggest that the current practice of administration of thromboprophylaxis (eg, dosing, timing of initiation, length of use) is ineffective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005828","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T22:00:39Z","timestamp":1737064839000},"page":"265-272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Postpartum Pharmacologic Thromboprophylaxis and Venous Thromboembolism in a U.S. Cohort"],"prefix":"10.1097","volume":"145","author":[{"given":"Ann M.","family":"Bruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda A.","family":"Allshouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Szychowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Jauk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Scharfstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torri D.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"R1-20250220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R2-20250220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/AOG.0000000000002062","article-title":"The case for a national maternal mortality review committee","volume":"130","author":"Clark","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R3-20250220","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"Thromboembolism in pregnancy. ACOG Practice Bulletin No. 196. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R4-20250220","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0000000000000230","article-title":"Postpartum venous thromboembolism: incidence and risk factors","volume":"123","author":"Tepper","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R5-20250220","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period","volume":"370","author":"Kamel","year":"2014","journal-title":"N Engl J Med"},{"key":"R6-20250220","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/AOG.0000000000001579","article-title":"National partnership for maternal safety: consensus bundle on venous thromboembolism","volume":"128","author":"D\u02bcAlton","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R8-20250220","doi-asserted-by":"crossref","first-page":"B11","DOI":"10.1016\/j.ajog.2020.04.032","article-title":"Society for Maternal-Fetal Medicine consult series #51: thromboembolism prophylaxis for cesarean delivery","volume":"223","author":"Pacheco","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250220","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","article-title":"Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery","volume":"88","author":"Mismetti","year":"2001","journal-title":"Br J Surg"},{"key":"R10-20250220","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"R11-20250220","first-page":"530","article-title":"Evaluation of a risk-stratified, heparin-based, obstetric thromboprophylaxis protocol","volume":"138","author":"Lu","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R12-20250220","first-page":"527","article-title":"Postpartum heparin thromboprophylaxis: more harm than good","volume":"138","author":"Kotaska","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R13-20250220","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/1471-0528.13706","article-title":"A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines","volume":"123","author":"Palmerola","year":"2016","journal-title":"BJOG"},{"key":"R14-20250220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2307\/2998560","article-title":"On the role of the propensity score in efficient semiparametric estimation of average treatment effects","volume":"66","author":"Hahn","year":"1998","journal-title":"Econometrica"},{"key":"R15-20250220","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2012-11-469551","article-title":"Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom","volume":"121","author":"Sultan","year":"2013","journal-title":"Blood"},{"key":"R16-20250220","first-page":"56","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"BJOG"},{"key":"R17-20250220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/rssb.12027","article-title":"Covariate balancing propensity score","volume":"76","author":"Imai","year":"2014","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"R18-20250220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"R20-20250220","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R21-20250220","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"R22-20250220","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"R23-20250220","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004318.pub5","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery","author":"Felder","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R24-20250220","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"R25-20250220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/AOG.0b013e3182029180","article-title":"Rate of wound complications with enoxaparin use among women at high risk for postpartum thrombosis","volume":"117","author":"Ferres","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R26-20250220","first-page":"697","article-title":"Efficacy of postpartum pharmacologic thromboprophylaxis: a systematic review and meta-analysis","volume":"141","author":"Oakes","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R27-20250220","article-title":"Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period","author":"Middleton","year":"2021","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R28-20250220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajog.2021.05.004","article-title":"Expert review: prevention of obstetrical venous thromboembolism","volume":"225","author":"Friedman","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20250220","first-page":"575","article-title":"Weight-based compared with fixed-dose enoxaparin prophylaxis after cesarean delivery: a randomized controlled trial","volume":"140","author":"Bruno","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R30-20250220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijoa.2013.05.008","article-title":"Peak plasma anti-Xa levels after first and third doses of enoxaparin in women receiving weight-based thromboprophylaxis following caesarean section: a prospective cohort study","volume":"22","author":"Hiscock","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"R31-20250220","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0000000000000873","article-title":"Enoxaparin dosing after cesarean delivery in morbidly obese women","volume":"125","author":"Overcash","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R32-20250220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/jp.2015.130","article-title":"A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women","volume":"36","author":"Stephenson","year":"2016","journal-title":"J Perinatol"},{"key":"R33-20250220","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ajh.23228","article-title":"Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity","volume":"87","author":"Freeman","year":"2012","journal-title":"Am J Hematol"},{"key":"R34-20250220","first-page":"223","article-title":"Trends in venous thromboembolism and associated risk factors during delivery hospitalizations from 2000 to 2018","volume":"139","author":"Krenitsky","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R35-20250220","doi-asserted-by":"crossref","first-page":"128.e1","DOI":"10.1016\/j.ajog.2023.11.013","article-title":"Postpartum pharmacologic thromboprophylaxis and complications in a US cohort","volume":"231","author":"Bruno","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20250220","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0040-1710314","article-title":"Treatment of venous thromboembolism in special populations with direct oral anticoagulants","volume":"120","author":"Bavalia","year":"2020","journal-title":"Thromb Haemost"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:01:13Z","timestamp":1740088873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005828","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"2024-09-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}